• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Apheresis Equipment - Global Strategic Business Report Product Image

Apheresis Equipment - Global Strategic Business Report

  • ID: 338516
  • August 2013
  • Region: Global, United States
  • 170 Pages
  • Global Industry Analysts, Inc

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets.

This report analyzes the worldwide markets for Apheresis Equipment in US$ Million by the following type of Apheresis and Procedure:

- Equipment by Type of Apheresis (Equipment for Therapeutic Apheresis, and Equipment for Donor Apheresis)
- Equipment by Type of Apheresis Procedure (Plasmapheresis, Erythrocytapheresis, Plateletpheresis, and Others).

The report profiles 16 companies including many key and niche players such as:

- Asahi Kasei Medical Co., Ltd.
- B Braun Melsungen AG
- Cerus Corporation
- Fenwal, Inc.
- Fresenius Medical Care North America
- Haemonetics Corp.
- HemaCare Corp.
- Kaneka Corporation
- Kawasumi Laboratories, Inc.
- Medica SpA
- NIKKISO Europe GmbH
- Terumo BCT
- Therakos, Inc.

Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.

For information on site licence pricing please click on Enquire before buying.

Note: Product cover images may vary from those shown

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

II. Executive Summary

1. INDUSTRY OVERVIEW
Apheresis Market: A Prelude
Growth Drivers in a Nutshell
Table 1: World Market for Apheresis Systems (2012): Percentage Breakdown of Value Sales by Leading Players (includes corresponding Graph/Chart)
Donor Apheresis: The Largest Segment
Therapeutic Apheresis to Witness Strong Growth
Key Market Trends & Drivers
Developing Nations to Lead the Charge in Future
Developed Markets: Traditional Revenue Generators
Rising Cancer Incidence to Drive Volume of Apheresis Procedures
Table 2: Number of New Cancer Cases Worldwide by Affected Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
Table 3: Global Cancer Incidence by Income Group: 2012 (in Thousands) (includes corresponding Graph/Chart)
Photopheresis: A Popular Therapeutic Apheresis Procedure
Plasmapheresis Continues to Lead the Apheresis Market
Table 4: Plasma Collection Methods: Percentage Breakdown by Fractionation and Extraction from Whole Blood (2013 Vs. 2010) (includes corresponding Graph/Chart)
Plateletpheresis Emerges as the ‘Treatment of Choice'
Increase in Number of Platelet Donors Drives Apheresis Procedures
Technological Advancements and Novel Indications Augur Well for Apheresis Market
Pediatrics: An Unexplored Domain in Therapeutic Apheresis
Automated Blood Processing Systems in Open Heart Surgeries
CFA - An Effective Way to Pull Up Cold Hemagglutinin Disease
Key Challenges & Issues
Lack of Awareness among Patients Restrains Market Growth
Vendors' Attitude Hampers Growth Prospects of Therapeutic Apheresis
Development of Inexpensive Apheresis Therapies
Scarcity of Qualified Donors
Challenges for Therapeutic Apheresis in the Unexplored Pediatrics Segment
Market Outlook

2. TECHNOLOGY OVERVIEW
Apheresis - The Definition
Apheresis Vs Whole Blood Collection
Comparison of Apheresis and Whole Blood Collection
The Process of Apheresis - An Overview
Blood Components
Apheresis Procedure
Duration, Frequency, and Efficiency of Apheresis
Segregation of Blood Components
Centrifugation
Centrifugal Cell Separators
Filtration
Side Effects
Types of Apheresis Procedures
Plasmapheresis
Plasma Exchange and Plasmapheresis: The Difference
Therapeutic Plasma Exchange (TPE) or Plasma Exchange
TPE: Abnormal Components Removed from Blood
Plasmapheresis: Potential Uses Discovered in the Early Years
Potential Use of Plasmapheresis in Select Diseases Discovered in the Early Years
Erythrocytapheresis
Plateletpheresis
Leukapheresis
Photopheresis
Functioning of THERAKOS™ - A Typical Photopheresis System
Lipidpheresis
Cytapheresis
Stem Cell Collection
Apheresis - A Review of Segmentation
Donor Apheresis
Process of Donor Apheresis
Automated Blood Donation Procedures
Safety of the Donor
Blood Components Required by Different Patients
Automated Apheresis
Therapeutic Apheresis: An Introduction
Therapeutic Apheresis Techniques
Applications of Therapeutic Apheresis
Categories of Indications for Therapeutic Apheresis
Therapeutic Apheresis is Remedial for Various Diseases
Indications for Therapeutic Apheresis
Type of Therapeutic Apheresis Procedure Used in Different Medication Conditions
Emerging Applications of Therapeutic Apheresis
Cost of Select Therapeutic Apheresis Procedures: An Overview
1. Photopheresis in GVHD (Graft-Versus-Host Disease)
2. Lipid Apheresis (LDL Apheresis)
3. Plasmapheresis and Other Procedures
Therapeutic Apheresis: What is the Risk Involved?
Replacement Fluid in Therapeutic Apheresis
Replacement Fluids Used in Therapeutic Apheresis
Various Replacement Fluids in Use
Select Replacement Fluids and their Limitations
Table 5: Fluid Balance in Fluid Replacement
Table 6: Volume Exchange of Plasma Constituents
Table 7: Removal of IgM and IgG by Plasma Exchange Volume
Table 8: Therapeutic Apheresis: Percentage Decrease and Restoration of Blood Components
Complications Involved and Suggested Treatment in the Therapeutic Apheresis Procedure
Therapeutic Plasmapheresis with Fresh Frozen Plasma (FFP) Replacement

3. BLOOD COMPONENTS & DERIVATIVES
Red Blood Cells (RBCs)
White Blood Cells (WBCs)
Platelets
Sources of Blood Plasma
Facts About Plasma and its Donation
Pre-requisites for Plasma Donors
The Complex Process of Becoming a Donor
Medical Screening
The Process of Plasma Donation
Select IQPP-authorized Plasma Collection Centers (US)
Ionic Composition of Blood
Types of Blood
General Facts about Blood
General Uses of Blood
Blood - Global Facts

4. PRODUCT AND TECHNOLOGICAL DEVELOPMENTS
Terumo BCT Receives FDA Approval for Enhancement to MNC Collection Protocol for Spectra Optia System
Fenwal Unveils Aurora™ Plasmapheresis System
Terumo BCT Introduces MNC Collection Protocol for Spectra Optia System
Terumo BCT Unveils New Therapeutic Apheresis Capabilities and Procedures
Terumo BCT Obtains FDA Approval for PF24 and PF24RT24 on TrimaAccel System
Fenwal Secures US FDA Approval for Therapeutic Plasma Exchange Protocol on Amicus® Separator
CaridianBCT Introduces MNC Collection Protocol for Spectra Optia Apheresis System
NxStage Medical Obtains FDA Approval for Therapeutic Plasma Exchange Cartridge
Health Canada Licenses CaridianBCT's new Protocol for Spectra Optia® Apheresis System
CaridianBCT Releases Spectra Optia Apheresis System Version 5
CaridianBCT Introduces Trima Accel® Version 6
CaridianBCT Introduces RBCX Protocol in Canada

5. RECENT INDUSTRY ACTIVITY
The Gores Group Acquires Therakos from Ortho-Clinical Diagnostics
Terumo BCT to Acquire Medservice
Fresenius Kabi Acquires Fenwal Holdings
CaridianBCT Collaborates with Terumo Transfusion to Form Terumo BCT
Fenwal's Aurora Plasmapheresis System Obtains FDA Clearance
Cerus to Enter into Partnership with BSI and American Red Cross to Commercialize INTERCEPT Plasma
Fenwal's Amicus System Obtains CE Mark Certification for a Therapeutic Plasma Exchange Protocol
Terumo Corp. Completes Acquisition of CaridianBCT
Fenwal Obtains FDA Approval for Collection of InterSol® Preserved Platelets using Amicus® Cell Separator
FDA Clears Fenwal's Software for Autopheresis-C® System
HemaCare Inks Commercial Cell Therapy Collection Agreement with Dendreon
HemaCare Inks Partnership Agreement with Dendreon

6. FOCUS ON SELECT GLOBAL PLAYERS
Asahi Kasei Medical Co., Ltd. (Japan)
B Braun Melsungen AG (Germany)
Cerus Corporation (US)
Fenwal, Inc. (US)
Fresenius Medical Care North America (FMCNA) (US)
Haemonetics Corp. (US)
HemaCare Corp. (US)
Kaneka Corporation (Japan)
Kawasumi Laboratories, Inc. (Japan)
Medica SpA (Italy)
NIKKISO Europe GmbH (Germany)
Terumo BCT (US)
Therakos, Inc. (US)

7. GLOBAL MARKET PERSPECTIVE
Table 9: World Recent Past, Current & Future Analysis for Apheresis Equipment Market by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 10: World Historic Review for Apheresis Equipment Market by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 11: World 15-Year Perspective for Apheresis Equipment Market by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
Table 12: World Recent Past, Current & Future Analysis for Equipment for Therapeutic Apheresis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 13: World Historic Review for Equipment for Therapeutic Apheresis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 14: World 15-Year Perspective for Equipment for Therapeutic Apheresis by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
Table 15: World Recent Past, Current & Future Analysis for Equipment for Donor Apheresis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 16: World Historic Review for Equipment for Donor Apheresis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 17: World 15-Year Perspective for Equipment for Donor Apheresis by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
Table 18: World Recent Past, Current & Future Analysis for Apheresis Equipment by Procedure Type - Erythrocytapheresis, Plasmapheresis, Plateletpheresis, and Others Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 19: World Historic Review for Apheresis Equipment by Procedure Type - Erythrocytapheresis, Plasmapheresis, Plateletpheresis, and Others Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 20: World 15-Year Perspective for Apheresis Equipment by Procedure Type - Percentage Breakdown of Dollar Sales for Erythrocytapheresis, Plasmapheresis, Plateletpheresis, and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A.Market Analysis
Current & Future Analysis
Apheresis Market - An Overview
Market Trends at a Glance
Opportunity Indicator:
Table 21: US Market for Blood Collection by Type: Percentage Breakdown by Blood Component for 2012 (includes corresponding Graph/Chart)
Blood Donations
Criteria for Platelet Donation
Criteria for Double Red Cell Donation
Plasma Donations
Table 22: Number of Plasma Donations Required Annually by Disease Type in the US: 2012 (includes corresponding Graph/Chart)
Therapeutic Apheresis Registers Strong Growth
Table 23: US Market for Therapeutic Apheresis (2013): Percentage Breakdown of Revenues Generated Through Procedures by Therapeutic Area (includes corresponding Graph/Chart)
An Overview of Regulatory Environment and Reimbursement Scenario
New Reimbursement Policies to Create Growth Opportunities for Therapeutic Apheresis
Medicaid Coverage for Therapeutic Apheresis by Various Conditions
Medicaid Coverage for Therapeutic Plasma Exchange
Medicaid covers therapeutic Cytapheresis for the following conditions:
Medicaid covers Extracorporeal Photopheresis (ECP) for the following conditions
Table 24: APC Payment Rates for Different Therapeutic Apheresis Procedures in 2012 & 2013 (In US$)
Competitive Scenario
Trima Accel, the Most Widely Used Platelet Collection Equipment in the US
Key Statistical Findings:
Table 25: US Market for Therapeutic Apheresis in Neurological Disorders (2012): Market Share Breakdown of Revenues by Company (includes corresponding Graph/Chart)
Table 26: US Market for Therapeutic Apheresis in Neurological Disorders (2012): Market Share Breakdown of Number of Procedures by Company (includes corresponding Graph/Chart)
Table 27: US Market for Therapeutic Apheresis in Hematology and Oncology Disorders (2012): Market Share Breakdown of Revenues by Company (includes corresponding Graph/Chart)
Table 28: US Market for Therapeutic Apheresis in Hematology and Oncology Disorders (2012): Market Share Breakdown of Number of Procedures by Company (includes corresponding Graph/Chart)
Product Launches
Strategic Corporate Developments
Select Players
B.Market Analytics
Table 29: US Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 30: US Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 31: US 15-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

2. CANADA
A.Market Analysis
Current & Future Analysis
B.Market Analytics
Table 32: Canadian Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 33: Canadian Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 34: Canadian 15-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

3. JAPAN
A.Market Analysis
Current & Future Analysis
Therapeutic Apheresis Market - An Overview
Key Finding
Table 35: Japanese Apheresis Market (2012): Market Share Breakdown by Leading Players (includes corresponding Graph/Chart)
Growing Demand for Cancer Treatments Drives Plateletpheresis Market
Select Players
B.Market Analytics
Table 36: Japanese Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 37: Japanese Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 38: Japanese 15-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

4. EUROPE
A.Market Analysis
Current & Future Analysis
B.Market Analytics
Table 39: European Recent Past, Current & Future Analysis for Apheresis Equipment by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 40: European Historic Review for Apheresis Equipment by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 41: European Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 42: European Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 43: European 15-Year Perspective for Apheresis Equipment by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
Table 44: European 15-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
4a. FRANCE
A.Market Analysis
Current & Future Analysis
B.Market Analytics
Table 45: French Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 46: French Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 47: French 15-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
4b. GERMANY
A.Market Analysis
Current & Future Analysis
Select Players
B.Market Analytics
Table 48: German Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 49: German Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 50: German 15-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
4c. ITALY
A.Market Analysis
Current & Future Analysis
Medica SpA - A Select Player
B.Market Analytics
Table 51: Italian Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 52: Italian Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 53: Italian 15-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
A.Market Analysis
Current & Future Analysis
B.Market Analytics
Table 54: UK Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 55: UK Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 56: UK 15-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
4e. SPAIN
A.Market Analysis
Current & Future Analysis
B.Market Analytics
Table 57: Spanish Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 58: Spanish Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 59: Spanish 15-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
4f. REST OF EUROPE
A.Market Analysis
Current & Future Analysis
B.Market Analytics
Table 60: Rest of Europe Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 61: Rest of Europe Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 62: Rest of Europe 15-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC
A.Market Analysis
Current & Future Analysis
B.Market Analytics
Table 63: Asia-Pacific Recent Past, Current & Future Analysis for Apheresis Equipment by Geographic Region
Australia, China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 64: Asia-Pacific Historic Review for Apheresis Equipment by Geographic Region - Australia, China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 65: Asia-Pacific Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 66: Asia-Pacific Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 67: Asia-Pacific 15-Year Perspective for Apheresis Equipment by Geographic Region - Percentage Breakdown of Dollar Sales for Australia, China and Rest of Asia-Pacific Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
Table 68: Asia-Pacific 15-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
5a. AUSTRALIA
A.Market Analysis
Current & Future Analysis
B.Market Analytics
Table 69: Australian Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 70: Australian Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 71: Australian 15-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
5b. CHINA
A.Market Analysis
Current & Future Analysis
B.Market Analytics
Table 72: Chinese Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 73: Chinese Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 74: Chinese 15-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
5c. REST OF ASIA-PACIFIC
A.Market Analysis
Current & Future Analysis
B.Market Analytics
Table 75: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 76: Rest of Asia-Pacific Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 77: Rest of Asia-Pacific 15-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

6. REST OF WORLD
A.Market Analysis
Current & Future Analysis

B.Market Analytics
Table 78: Rest of World Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
Table 79: Rest of World Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
Table 80: Rest of World 15-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 16 (including Divisions/Subsidiaries - 23)
The United States (11)
Japan (4)
Europe (8)
- Germany (6)
- Italy (2)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos